Helicobacter pylori infection and extragastric diseases in 2017

Helicobacter

Volumn 22, Issue , 2017, Pages

  de Korwin, Jean Dominique ^a   Ianiro, Gianluca ^b   Gibiino, Giulia ^b   Gasbarrini, Antonio ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

allergy; chronic kidney diseases; inflammatory bowel diseases; metabolic syndrome; neurological disorders; nonalcoholic fatty liver

Indexed keywords

IMMUNOGLOBULIN G; LEVODOPA;

ALLERGIC ASTHMA; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; CHRONIC URTICARIA; CORONARY ARTERY DISEASE; DEMENTIA; DISEASE ASSOCIATION; EOSINOPHILIC ESOPHAGITIS; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; KIDNEY DYSFUNCTION; LOW BIRTH WEIGHT; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS ADENOCARCINOMA; PARKINSON DISEASE; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISEASE; TREATMENT RESPONSE; ASTHMA; BACTERIAL SKIN DISEASE; GASTROINTESTINAL DISEASE; ISOLATION AND PURIFICATION; KIDNEY DISEASE; PATHOLOGY; RESPIRATORY TRACT INFECTION;

ASTHMA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATORY BOWEL DISEASES; KIDNEY DISEASES; METABOLIC SYNDROME; NERVOUS SYSTEM DISEASES; RESPIRATORY TRACT INFECTIONS; SKIN DISEASES, BACTERIAL;

EID: 85029180918     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12411     Document Type: Review

References (71)

1. Çamcı G, Oğuz S. Association between Parkinson's Disease and Helicobacter pylori. J Clin Neurol. 2016;12:147-150.
2. Mridula KR, Borgohain R, Chandrasekhar Reddy V, Bandaru VCh, Suryaprabha T. Association of Helicobacter pylori with Parkinson's Disease. J Clin Neurol. 2017;13:181-186.
3. Suwarnalata G, Tan AH, Isa H, Gudimella R, et al. Augmentation of autoantibodies by Helicobacter pylori in Parkinson's disease patients may be linked to greater severity. PLoS ONE. 2016;11:e0153725.
4. Yao G, Wang P, Luo XD, Yu TM, Harris RA, Zhang XM. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neurosci Lett. 2016;620:1-7.
5. Jaruvongvanich V, Sanguankeo A, Jaruvongvanich S, Upala S. Association between Helicobacter pylori infection and multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2016;7:92-97.
6. Deretzi G, Gavalas E, Boziki M, et al. Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome. Acta Neurol Scand. 2016;133:268-275.
7. Efthymiou G, Dardiotis E, Liaskos C, et al. Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis. J Neuroimmunol. 2016;298:19-23.
8. Shindler-Itskovitch T, Ravona-Springer R, Leibovitz A, Muhsen K. A systematicrReview and meta-analysis of the association between Helicobacter pylori infection and dementia. J Alzheimers Dis. 2016;52:1431-1442.
9. Miklossy J, McGeer PL. Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation. Aging (Albany NY). 2016;8:575-588.
10. Xu Y, Wang Q, Liu Y, Cui R, Zhao Y. Is Helicobacter pylori infection a critical risk factor for vascular dementia? Int J Neurosci. 2016;126:899-903.
11. Schulz C, Schütte K, Reisener N, Voss J, Malfertheiner P. Prevalence of Helicobacter pylori infection in patients with minimal hepatic encephalopathy. J Gastrointestin Liver Dis. 2016;25:191-195.
12. Kountouras J, Polyzos SA, Gavalas E, et al. A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology. J Gastrointestin Liver Dis. 2016;25:405-406.
13. Kountouras J, Boziki M, Polyzos SA, et al. Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis. Free Radic Res. 2017;51:73-79.
14. Ma ZF, Majid NA, Yamaoka Y, Lee YY. Food Allergy and Helicobacter pylori Infection: a systematic review. Front Microbiol. 2016;7:368.
15. von Arnim U, Wex T, Link A, Venerito M, Miehlke S, Malfertheiner P. Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016;43:825-830.
16. den Hollander WJ, Sonnenschein-van der Voort AM, Holster IL, et al. Helicobacter pylori in children with asthmatic conditions at school age, and their mothers. Aliment Pharmacol Ther. 2016;43:933-943.
17. Wang YC, Lin TY, Shang ST, Chen HJ, Kao CH, Wu CC, Yang TY. Helicobacter pylori infection increases the risk of adult-onset asthma: a nationwide cohort study. Eur J Clin Microbiol Infect Dis. 2017 Apr 8. https://doi.org/10.1007/s10096-017-2972-1. [Epub ahead of print]
18. Zhou S, Huang Y, Liang B, et al. Systemic and mucosal pre-administration of recombinant Helicobacter pylori neutrophil-activating protein prevents ovalbumin-induced allergic asthma in mice. FEMS Microbiol Lett. 2017;364(2):fnw288.
19. Kyburz A, Müller A. Helicobacter pylori and extragastric diseases. Curr Top Microbiol Immunol. 2017;400:325-347.
20. Lee HY, Kim JW, Lee JK, Heo EY, Chung HS, Kim DK. Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori. Int J Chron Obstruct Pulmon Dis. 2016;11:2055-2062.
21. Lahat A, Kopylov U, Neuman S, et al.,on behalf of the Israeli IBD research Network (IIRN). Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease. BMC Gastroenterol. 2017;17:27.
22. Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. 2017;66:235-249.
23. Lord AR, Simms LA, Hanigan K, Sullivan R, Hobson P, Radford-Smith GL. Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain. Gut. 2017 Apr 13. pii: gutjnl-2017-313805. https://doi.org/10.1136/gutjnl-2017-313805
24. Shen Z, Mannion A, Whary MT, et al. Helicobacter saguini, a novel Helicobacter isolated from cotton-top tamarins with ulcerative colitis, has proinflammatory properties and induces typhlocolitis and dysplasia in gnotobiotic IL-10-/- Mice. Infect Immun. 2016;84:2307-2316.
25. Magen E, Waitman DA, Goldstein N, Schlesinger M, Dickstein Y, Kahan NR. Helicobacter pylori infection in patients with selective immunoglobulin a deficiency. Clin Exp Immunol. 2016;184:332-337.
26. Tan RJ, Sun HQ, Zhang W, et al. A 21-35 kDa Mixed protein component from Helicobacter pylori activates mast cells effectively in chronic spontaneous urticaria. Helicobacter. 2016;21:565-574.
27. Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176:100-106.
28. Saleh P, Naghavi-Behzad M, Herizchi H, Mokhtari F, Mirza-Aghazadeh-Attari M, Piri R. Effects of Helicobacter pylori treatment on rosacea: a single-arm clinical trial study. J Dermatol. 2017 Apr 28. https://doi.org/10.1111/1346-8138.13878. [Epub ahead of print].
29. Lewinska A, Wnuk M. Helicobacter pylori-induced premature senescence of extragastric cells may contribute to chronic skin diseases. Biogerontology. 2017;18:293-299.
30. Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, et al. Association between Helicobacter pylori and end-stage renal disease: a meta-analysis. World J Gastroenterol. 2017;23:1497-1506.
31. Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, et al. Association of Helicobacter pylori with chronic kidney diseases: a meta-analysis. Dig Dis Sci. 2017 Mar 6. https://doi.org/10.1007/s10620-017-4516-z. [Epub ahead of print].
32. Cheungpasitporn W, Thongprayoon C, Wijarnpreecha K, et al. Decline in prevalence and risk of Helicobacter pylori in kidney transplant recipients: a systematic review and meta-analysis. J Evid Based Med. 2017 May 2. https://doi.org/10.1111/jebm.12252. [Epub ahead of print].
33. Wang JW, Hsu CN, Tai WC, et al. The association of Helicobacter pylori eradication with the occurrences of chronic kidney diseases in patients with peptic ulcer diseases. PLoS ONE. 2016;11:e0164824.
34. Zhu TT, Wang L, Wang HL, He Y, Ma X, Fan JM. Helicobacter pylori participates in the pathogenesis of IgA nephropathy. Ren Fail. 2016;38:1398-1404.
35. Nanbakhsh F, Behrouzi-Lak T, Tabean M, Oshnouei S, Mazlumi P. Association of Helicobacter pylori infection and ectopic pregnancy. J Family Reprod Health. 2016;10:80-84.
36. Den. Hollander WJ, Schalekamp-Timmermans S, Holster IL, et al. Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth. Helicobacter. 2017;22(2). https://doi.org/10.1111/hel.12364. Epub 2016 Oct 27.
37. Di Simone N, Tersigni C, Cardaropoli S, et al. Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences. Helicobacter. 2017;22(2). https://doi.org/10.1111/hel.12347. Epub 2016 Aug 3.
38. Wanyama R, Kagawa MN, Opio KC, Baingana RK. Effect of maternal Helicobacter pylori infection on birth weight in an urban community in Uganda. BMC Pregnancy Childbirth. 2016;16:158.
39. Grooten IJ, Den Hollander WJ, Roseboom TJ, Kuipers EJ, Jaddoe VW, Gaillard R, Painter RC. Helicobacter pylori infection: a predictor of vomiting severity in pregnancy and adverse birth outcome. Am J Obstet Gynecol. 2017;216:512. e1-512.e9
40. Göymen A, Özdurak İ, Özkaplan ŞE, Şimsek Y, Avcı F, Akpak YK. The relationship between the Helicobacter pylori seropositivity with systemic and local oxidative status and hyperemesis gravidarum: a pilot study. J Matern Fetal Neonatal Med. 2017;12:1-5.
41. Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2015;20:125-132.
42. Upala S, Jaruvongvanich V, Riangwiwat T, Jaruvongvanich S, Sanguankeo A. Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis. J Dig Dis. 2016;17:433-440.
43. Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45:1219-1222.
44. Franceschi F, Niccoli G, Ferrante G, Kountouras J. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinicopathological study and a meta-analysis of 4241 cases. Atherosclerosis. 2009;202:535-542.
45. Zuin M, Rigatelli G, Del Favero G, et al. Coronary artery disease and Helicobacter pylori infection: should we consider eradication therapy as cardiovascular prevention strategy? Int J Cardiol. 2016;223:711-712.
46. Franceschi F, Gasbarrini A, Polyzos SA, et al. Extragastric diseases and Helicobacter pylori. Helicobacter. 2015;20(Suppl 1):40-46.
47. Kountouras J, Polyzos SA, Zavos C, et al. Helicobacter pylori might contribute to non-alcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors. Hepatology. 2014;60:1450-1451.
48. Kountouras J, Polyzos SA, Katsinelos P, et al. Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: we consider eradication therapy as a potential cardio-cerebrovascular prevention strategy. Int J Cardiol. 2017;229:17-18.
49. Yu XJ, Yang X, Feng L, Wang LL, Dong QJ. Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: a meta-analysis. Exp Ther Med. 2017;13:787-793.
50. Kountouras C, Polyzos SA, Stergiopoulos C, et al. A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke. Sleep Med. 2017;34:256.
51. Kachuei A, Amini M, Sebghatollahi V, Feizi A, Hamedani P, Iraj B. Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: a pilot study and single-blind randomized controlled clinical trial. J Res Med Sci. 2016;21:8.
52. Nasif WA, Mukhtar MH, Eldein MMN, Ashgar SS. Oxidative DNA damage and oxidized low density lipoprotein in Type II diabetes mellitus among patients with Helicobacter pylori infection. Diabetol Metab Syndr. 2016;8:34.
53. Rabelo-Gonçalves EMA, Roesler M, Zeitune JMR. Extragastric manifestations of Helicobacter pylori infection: possible role of bacterium in liver and pancreas diseases. World J Hepatol. 2015;7:2968-2979.
54. Gomez-Rubio P, Rosato V, Marquez M, et al., on behalf of the PanGenEU Study Investigators. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Ann Oncol. 2017 Apr 5. https://doi.org/10.193/annonc/mdx167
55. Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Dig Dis. 2010;28:162-168.
56. Polyzos SA, Kountouras J, Zavos C, Deretzi G. Helicobacterpylori Infection and insulin resistance. Helicobacter. 2013;18:165-166.
57. Sumida Y, Kanemasa K, Imai S, et al. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol. 2015;50:996-1004.
58. Kim TJ, Sinn DH, Min YW, et al. A cohort study on Helicobacter pylori infection associated with non-alcoholic fatty liver disease. J Gastroenterol. 2017 Apr 5. https://doi.org/10.1007/s00535-017-1337-y.
59. Okushin K, Takahashi Y, Yamamichi N, et al. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol. 2015;15:25.
60. Baeg MK, Yoon SK, Ko SH, et al. Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22:2592-2600.
61. Tang DM, Kumar S. The association between Helicobacter pylori infection and nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 2017;19:5.
62. Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Manatsathit W, Jaruvongvanich V, Ungprasert P. Helicobacter pylori and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2017 Jan 17. https://doi.org/10.1097/MCG.0000000000000784.
63. Cheng DD, He C, Ai HH, Huang Y, Lu NH. The possible role of Helicobacter pylori in non-alcoholic fatty liver disease. Front Microbiol. 2017;8:743.
64. Hossain IA, Akter S, Bhuiyan FR, Shah MR, Rahman MK, Ali L. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with non-alcoholic fatty liver disease. BMC Res Notes. 2016;9:266.
65. Zhou X, Liu W, Gu M, Zho H, Zhou H, Zhang G. Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR- 203/SOCS3 signaling pathway. J Gastroenterol. 2015;50:1027-1040.
66. Polyzos SA, Aronis KN, Kountouras J, Raptis DD, Vasiloglou MF, Mantzoros CS. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia. 2016;59:30-43.
67. Xu MY, Liu L, Yuan BS, Yin J, Lu QB. Association of obesity with Helicobacter pylori infection: a retrospective study. World J Gastroenterol. 2017;23:2750-2756.
68. Jiang W, Wu N, Wang X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5:8096.
69. Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13:412-425.
70. Khosravi Y, Seow SW, Amoyo AA, et al. Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice. Sci Rep. 2015;5:8731.
71. Kountouras J, Polyzos SA, Zeglinas C, et al. Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort. Gastrointest Endosc. 2017;85:462-463.